Exchange: NASDAQ·Updated 07:30 PM EST

VMD News

News
all
press releases
Viemed Healthcare (VMD) Q3 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
Viemed Healthcare (VMD) Q3 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
More News
Viemed Healthcare (VMD) delivered earnings and revenue surprises of -8.33% and -0.13%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
CeriBell, Inc. (CBLL) delivered earnings and revenue surprises of +4.00% and +0.70%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Boston Scientific (BSX) delivered earnings and revenue surprises of 0.00% and +0.68%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Investors need to pay close attention to VMD stock based on the movements in the options market lately.
Zacks
Viemed Healthcare (VMD) delivered earnings and revenue surprises of -30.00% and +0.38%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
SNDL INC (SNDL) delivered earnings and revenue surprises of -100.00% and -1.53%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Viemed Healthcare (VMD) delivered earnings and revenue surprises of -33.33% and +0.55%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Viemed Healthcare (NASDAQ:VMD - Get Free Report) announced its earnings results on Tuesday. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.03). Viemed Healthcare had a net margin of 5.53% and a return on equity of 10.72%. The firm had...
MarketBeat
Bio-Rad (BIO) delivered earnings and revenue surprises of -31.77% and +1.83%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks

Advertisement|Remove ads.